Rebecca has fifteen years of experience in the health care investment business and joined Deep Track Capital prior to its launch in April 2021. She joined DTC from New Leaf Venture Partners where she worked for six years, most recently as a Principal leading the crossover and public company strategy. Previously, she spent four years on the sell side at both Jefferies and Piper Jaffray, covering biotechnology and specialty pharmaceuticals companies. Rebecca started her career as an investment banking analyst in the health care group of Bank of America and as a venture capital associate at Bay City Capital. Rebecca earned a Bachelor of Science in Biochemistry and Mathematics from Indiana University.
Rebecca Luse
